New market launch: TIEFENBACHER PHARMACEUTICALS successfully launches the generic version of Teriflunomide in more than 20 European countries

We are thrilled to announce that we at AET – Tiefenbacher Pharmaceuticals have successfully prepared a day one launch of the generic version of Teriflunomide.

This complex launch follows Tiefenbacher Group`s strategy to make high quality pharmaceuticals better affordable and better available for patients worldwide.

Teriflunomide is used to treat Multiple Sclerosis – a chronic disease that effects the central nervous system. The 14 mg film coated tablets are developed and produced in Tiefenbacher Group`s own sites and will be marketed by our partners, well-known international pharmaceutical companies. Our product has already been successfully launched in the US, Canada, Mexico, and Australia before. Further markets will follow shortly.

Tiefenbacher Pharmaceuticals, a part of Tiefenbacher Group, develops and commercializes generic, value added, and innovative pharmaceuticals as well as medical devices worldwide. We provide over 180+ pharmaceutical products across various therapeutic categories in 10+ dosage forms. With our in-house product development and manufacturing, we can address specific therapeutic needs in unique formulations of prescription drugs (Rx) and over-the-counter (OTC) medicines for global markets (including highly potent drugs).  

For more information about our finished dosage forms and healthcare solutions, please contact Tiefenbacher Pharmaceuticals: or please visit us

About Tiefenbacher Group – Pioneering Healthcare since 1963

Tiefenbacher Group is a purpose-driven and 100% family-owned healthcare company providing best-in-class solutions along the entire pharmaceutical value chain. From the initial idea to market access of high-quality medicines around the world: We distribute APIs and develop, produce, and register finished dosage forms (FDFs) including highly potent drugs as well as medical devices. Our purpose is to improve people’s lives by making pharmaceuticals more affordable, more available, and better than ever before.

For further information about TIEFENBACHER GROUP and our solutions for better healthcare and our in-house capabilities to develop and commercialize pharmaceutical products for global markets (including highly potent drugs) please contact us by email at or visit us on: